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http:WHAT THIS PAPER ADDS
In vascular surgery, large registry studies have an important role in quality control and as a source of patients in
scientiﬁc reports. Registry based studies describe the outcome in true practice in non-selected patients. The key
issue, however, is the validity of the registries. The Vascunet collaboration group has started the validation of the
participating registries. This study reports the results of the validation of the Swedish vascular registry made by
two independent validators. The validators visited ﬁve Swedish hospitals, which perform more than one third of
all vascular procedures in Sweden.Background: International comparison of registry data within vascular surgery has previously been published by
Vascunet. One of the limitations of such comparisons is data validity and completeness, and meaningful
interpretation of differences between countries can only be made if the data are robust within each of the
countries studied. The Vascunet collaboration has therefore embarked on a validation exercise of international
vascular registry data.
Methods: Five out of 20 hospitals performing vascular surgery in Sweden were visited by two international
validators. Independent evaluation of the procedures of carotid endarterectomy and infrarenal abdominal aortic
aneurysm repair was performed, and local hospital administrative data were compared with Swedvasc registry
data. External validation compared the numbers of cases in these two systems of data collection and internal
validation compared data accuracy and completeness within individual patient records.
Results: Hospital records identiﬁed 335 carotid and 393 abdominal aortic aneurysm (AAA) procedures, whereas
Swedvasc identiﬁed 331 carotid and 359 AAAs. Nine carotid procedures and 64 AAA procedures were found in
hospital administrative data but not in Swedvasc, and 14 carotids and 30 AAAs were found in Swedvasc but not in
hospital data. External validity was 100% (95% CI 98.8e100%) for carotids and 98.8% (95% CI 96.9e99.5%) for
AAAs. In internal validation, 0.8% of variables were missing in hospital data compared with Swedvasc and 4.2%
were missing in Swedvasc compared with hospital data. Data contained within the data ﬁelds of Swedvasc and
hospital data were the same in 97.4% (95% CI 96.3e98.3%) for carotids and 96.2% (CI 94.9e97.2%) for AAAs.
Conclusion: This study has provided a template for international validation of registry data and has demonstrated
that Swedvasc is a highly accurate system of data collection for Swedish vascular surgery.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Vascunet is an international collaboration set up to compare
practice between countries for common vascular in-
terventions. Data analysis, using national and regional registry
data, has been undertaken for infrarenal abdominal aortic
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//dx.doi.org/10.1016/j.ejvs.2015.07.021bypass, and popliteal aneurysm intervention, and these
comparisons of practice have been previously published.1e5
These analyses have revealed differences in practices and
outcomes between countries but have also highlighted that
the extent and quality of data collection vary considerably.
Therefore, a persistent concern surrounding this type of
registry data comparison, from both within the Vascunet
committee and from peer reviewers, is that validation of
the data is insufﬁcient.
International audit also poses a particular problem with
regard to how representative the data of the population
within the country fromwhich they are derived are. It is quite
possible for large numbers of patients to be submitted but for
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performed. It is therefore important to examine not only the
quality of data with respect to accurate recording of clinical
information but also to examine the completeness of the
data. The latter includes how well individual data ﬁelds are
completed but also whether all patients treated are included.
Two validation questions are therefore important when
assessing registry data: (1) Are all the cases recorded in the
registry, and (2) Are the recorded data accurate? External
validation in the current study answers the ﬁrst question and
internal validation answers the second.
In response to these concerns Vascunet has now
embarked on a system of validation of national data, and is
committed to improving registry data in order to allow
meaningful international comparison of data, thereby
enabling improvement of outcomes from vascular inter-
vention. Hungary was the ﬁrst country to be validated and
the results of this validation have been published.6 The
processes used in this initial validation formed the basis for
developing a template for use in subsequent validations.
The second country to be validated was Sweden and this
report details the ﬁndings of that validation.Swedvasc registry
A group of enthusiastic vascular surgeons ﬁrst started the
registry in 1986, and by 1991 most of the population of
Sweden was covered. The registry has been developed and
reﬁned year on year, now reporting on more than 220,000
procedures. The registry reports annually, based on ﬁgures
submitted by individual vascular centres throughout Swe-
den (current population 9,636,741). It is not compulsory to
enter data into the registry in the legal sense. There has
been, however, a strong competitive tradition ever since the
registry was founded in 1987, with publication of centre
speciﬁc external and internal validation results. Centres
with near 100% registration have been highlighted and
given credit, and those with inferior results have also been
highlighted, which often has resulted in improved results
the following year. After almost 30 years of improving val-
idity, the Swedvasc team reports that this improves results.
Swedvasc has never published surgeon speciﬁc outcomes.
The Swedvasc view is that the surgeon speciﬁc results
belong to the individual centres. In their opinion only the
individual centres know who operates on the most difﬁcult
cases, and if a surgeon needs to improve her/his results, or
be removed from practice. The registry only evaluates the
performance of the centres, and these have been published
openly on the website since 1997.
The local hospitals are responsible for data collection and
entry, without ﬁnancial help from the central level. This is a
natural part of the work, as natural as writing the history of
the operation in the case record. The larger units often have
research nurses or secretaries doing part of the registration,
and certainly checking and reminding. Recently, Swedvasc
has employed regional part time nurses who help in
reminding about incomplete registration, etc., which is
ﬁnanced by central money.METHODS
The validation of the Swedvasc registry was performed by
two independent validators (T.L., M.V.), who visited ﬁve of
the 31 hospitals in Swedvasc during two visits to Sweden.
The ﬁve hospitals cover 36% (342/948) of the carotid artery
procedures performed for stroke prevention and reported
to the Swedvasc during 2012 and 28% (357/1269) of the
AAA procedures. The hospitals were picked randomly but in
such a way that allowed the ﬁve hospitals to be visited on
the two site visits. The hospitals included in the ﬁrst visit in
January 2014 were Uppsala University Hospital (Hospital 1)
(T.L. and M.V.), Vasterås Hospital (Hospital 2) (T.L.), and
Södersjukhuset in Stockholm (Hospital 3) (M.V.). Visits to
Skåne University Hospital in Malmö (Hospital 4) (M.V.) and
Helsingborg Hospital (Hospital 5) (T.L.) took place in April
2014. Both external validation and internal validation
(described below) were performed in each hospital: 95%
conﬁdence intervals were calculated for external validity of
all data, and internal validity in each hospital as well as total
data.
In Swedvasc, procedures are registered in seven different
modules: carotid artery procedures (for stroke prevention),
infrarenal abdominal aortic aneurysm disease, other aortic
disease (juxta/suprarenal, thoracic, and thoraco-
abdominal), infrainguinal occlusive disease (including
popliteal artery aneurysms), miscellaneous other arterial
procedures, miscellaneous other venous procedures and re-
operations. Shortly beforehand the validators had informed
the hospitals that procedures registered to the modules for
AAA and carotid stenosis performed during the calendar
year 2012 would be retrospectively reviewed, so that hos-
pital administrative data would be obtained before the site
visit for external validation to be performed.External validation
In external validation the comprehensiveness of the
Swedvasc data was evaluated by comparing patients and
procedures in Swedvasc with hospital administrative data.
The hospital administration provided the information on
the hospital registry data of all the procedures performed
for AAA and carotid artery stenosis between January 1,
2012, and December 31, 2012. Data included operation
codes, operation date, and the patient’s identity code.
The Swedvasc data were provided by the national
representative of the Swedvasc registry (Thomas Troëng).
All the procedures that were registered to the carotid
module and infrarenal aortic module that were performed
during the period January 1, 2012, to December 31, 2012,
including the patient’s identity code, were selected.
The external validation was performed by crosslinking the
identity codes including operation date between hospital
data and Swedvasc data on the AAA and carotid pro-
cedures. Thereafter, all the cases that were in hospital re-
cords but not in Swedvasc data were checked one by one
using both Swedvasc and hospital case records. Similarly, all
the cases that were found in the Swedvasc registry but that
were missing from the Hospital records were reviewed.
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Internal validation was performed by comparing the data
held in individual data ﬁelds in the Swedvasc registry with
data in patients’ case histories in a random sample of pa-
tients chosen by the validators. Fifteen data ﬁelds in the
carotid cases and 13 in AAA cases were checked (Table 1). In
each hospital, the validators aimed to evaluate 20 aortic
and 15 carotid cases, although in practice due to time
constraints on the day this number could not be achieved in
all hospitals visited. This comparison was done manually by
interrogating the electronic case histories with Swedvasc
data that was also available electronically.
RESULTS
External validation
The data search from the hospital registries of the ﬁve
hospitals revealed 335 carotid and 393 AAA procedures
performed during 2012. The corresponding ﬁgures from
the Swedvasc registry were 331 carotid and 359 AAA
procedures. After crosslinkage of the identity codes, nine
carotid procedures and 64 AAA procedures were initially
found from hospital records but not from the Swedvasc
registry. Fourteen carotid procedures and 30 AAA pro-
cedures were found in the Swedvasc registry but were not
in the data extracted from the hospital administrative data.
After review of the individual case records and Swedvasc
records of these missing cases, however, further matching
of cases was performed, and following this there were no
carotid procedures and four AAA procedures missing from
the Swedvasc registry resulting in 100% external validity inTable 1. Data ﬁelds compared for internal validation.
Carotid endarterectomy Infrarenal abdominal aortic
aneurysm
Sex Sex
Age Age
Side Smoking
Smoking Diabetes
Diabetes Aortic abdominal aneurysm
diameter
Indication Operation type
Degree of stenosis Ruptured/non-ruptured
Type of surgery Planned/unplanned
Use of shunt Blood loss
Use of patch Post-operative coronary event
Post-operative
cranial nerve injury
Renal failure
Post-operative
acute coronary
syndrome
Limb ischaemia
Post-operative
transient ischaemic
attack
Conversion of endovascular
aneurysm repair to open
Post-operative stroke Abdominal compartment
syndrome
Re-operation 30 day mortality
30 day mortality 90 day mortality
90 day mortalitycarotid surgery and 99% external validity in AAA pro-
cedures (Table 2). In addition there was one thoraco-
abdominal aortic aneurysm (TAAA) case that appeared in
hospital records and should have been registered to the
TAAA module but was missing from Swedvasc. The most
common reason (n ¼ 58) for the procedure not appearing
in the Swedvasc data search was that it had been regis-
tered to a different module in the registry; most commonly
they had been correctly registered to a re-operation
module or, in the case of AAA, to the TAAA module
(Table 3). The external validity in the ﬁve hospitals is
presented in the Table 2.
The mortality of the ﬁve cases (4 AAA patients and 1
TAAA patient) was checked at the time of validation and all
patients were alive. This check was done to rule out the
possibility that the reason they were missing from Swed-
vasc was a bad outcome.Internal validation
Internal validation was performed on 72 carotid and 90 AAA
cases that were picked randomly from the dataset common
to both local data and Swedvasc. The number of patients
studied in each hospital was 13e15 carotid cases and 15e
21 AAA cases. The variables listed in the methods section
were compared for local data and from Swedvasc as pre-
viously described. Overall, 1,051 data entries in carotid
cases and 1,170 data entries in AAA cases were checked. Of
these, 17 (0.8%) variables were missing in local data
compared with Swedvasc. The number of missing variables
in Swedvasc was 93 (4.2%) The majority of missing variables
were risk factors (n ¼ 68, 7.3%); as in Hospital 4, the pre-
operative risk factors (diabetes and smoking) were regis-
tered in only one of 35 patients studied. In Hospital 1, 13
post-operative variables were missing because these pa-
tients were followed up in another hospital. In the end,
1,017 carotid variables and 1,128 AAA variables were
compared with each other. With respect to accuracy of data
ﬁelds, different responses were obtained from local data
and from Swedvasc in 26 carotid patients and 43 AAA pa-
tients, resulting in an internal validity of 97.4% for carotid
data and 96.2% for AAA data (Table 4). Eighteen out of
these 69 (26.1%) were for the data ﬁeld of smoking. Post-
operative stroke and transient ischaemic attack as well as
30 and 90 day mortality had 100% agreement between the
two different systems.
DISCUSSION
Vascunet, a subcommittee of the European Society of
Vascular Surgery, aims to increase knowledge and under-
standing of vascular disease, and to promote excellence in
vascular surgery by means of international vascular audit.
The group comprises vascular representatives from 10
countries and has published extensively on international
vascular outcome data using registry data.1e5 The group
believes that vascular registries are of the utmost impor-
tance in the quality control of a vascular surgical unit. They
serve as a source of data in population based studies and
Table 2. The external validity in the ﬁve hospitals.
Number of hospital
1 2 3 5 4 Total
Carotid
Procedures in hospital data 31 35 118 32 119 335
Procedures in Swedvasc 35 35 117 31 113 331
Procedures in Swedvasc but not in local data 4 0 9 1 0 14
Procedures in local data but not in Swedvasc 0 0 1 2 6 9
Procedures common in local data and Swedvasc 31 35 117 30 113 326
True number of missing cases from Swedvasc 0 0 0 0 0 0
True number of missing cases from hospital
records
0 0 3 0 0 3
External validity of Swedvasc (%) 100 100 100 100 100 100% (95% CI 98.8e100%)
AAA
Procedures in hospital data 49 48 98 53 145 393
Procedures in Swedvasc 51 45 91 51 121 359
Procedures in Swedvasc but not in local data 13 3 8 3 3 30
Procedures in local data but not in Swedvasc 11 6 15 5 27 64
Procedures common in local data and Swedvasc 38 42 83 48 117 328
True number of missing cases from Swedvasc 0 0 2 1 1 4
True number of missing cases from hospital
records
0 0 2 0 0 2
External validity of Swedvasc (%) 100 100 97.6 97.9 99.1 98.8% (95% CI 96.9e99.5%)
Swedvasc Validation 805allow monitoring of outcomes in a large number of patients
who are treated in daily practice.
It is clear that different countries are at very different
stages in recording and publishing outcomes from vascular
intervention; nevertheless, in recent years the number of
vascular registries has increased and there is a steady trend
towards publication of results. In the UK this has recently
moved to a level of individual surgical outcome data.7Table 3. The reasons why patients were in hospital records but not
found in Swedvasc (A) and the reasons why they were not found
from hospital records but they were in Swedvasc (B).
A Carotid AAA
True missing cases from the Swedvasc 4
Patient recorded to another module 7 58
Patient operated in 2011, left hospital 2012 1 2
Patient was incorrectly recorded twice in
hospital records
1
B Carotid AAA
True missing cases from the hospital records 3 2
No reason why the data search did not
pick up the patient
6 13
The code was not in the searching list 4 2
Incorrect code in hospital records but
correct in Swedvasc
4
Correct code in hospital records but
incorrect in Swedvasc
2
Patient was operated on in 2012 but
left hospital in 2013
1
Patient was operated on in another
hospital (common on call system)
2
Wrong year in Swedvasc 1
ID in different mode in matching process 1
Incorrect ID in Swedvasc
Incorrect module in Swedvasc 1
Were correctly recorded but in the
old hospital system
2Medical registry data need to be accurate in order to be
able to draw meaningful conclusions. The data contained in
a registry, and publications and quality reports based on
these data, are of little value if the registry data are unre-
liable. International data comparison poses a particular
challenge in ensuring consistency of data between coun-
tries. Studies of data quality have suggested various classi-
ﬁcations of error, including interpretation errors,
documentation errors and coding errors.8 Despite this there
is no internationally agreed method of data validation for
registries, although Arts et al.9 have attempted to deﬁne a
framework of procedures for data quality assurance in
medical registries, involving procedures, in central coordi-
nation of data and in local data collection. The Vascunet
group have therefore developed a process for international
validation of vascular outcome data, based on previous
experience in a pilot study.6
In this study the Swedvasc registry was validated and
both external and internal validation were done. External
validation answers the question: Are all the cases recorded
in the registry? The Swedvasc registry was found to have
very good correlation with local hospital clinical and
administrative data for external validation. With only a very
small number of exceptions all the patients who were
operated on in the validated hospitals during the year
examined (2012) were also registered in the Swedvasc
registry. Most of the discrepancies that were found be-
tween the two data systems were due to either registration
in Swedvasc under different modules, or to patients being
coded as a different procedure in local administrative data.
In some cases it was felt by the local teams that there was
no satisfactory code available. There were a handful of cases
found in Swedvasc that were not in the hospital adminis-
trative data due to errors in the hospital recording systems.
There is a long tradition of recording outcomes by a
Table 4. Internal validity in the visited hospitals.
Number of hospital
1 2 3 4 5 Total
Carotid
Patients reviewed 15 13 14 15 15 72
Variables total 225 195 196 210 225 1051
Data missing in Swedvasc 0 0 1 30 0 31
Data not known in Swedvasc 7 0 1 0 0 8
Data not available from case records 7 1 0 0 4 12
Variables available for internal validation 218 194 194 190 221 1017
Data discrepancy between Swedvasc and case
records
6 5 6 5 4 26
Internal validity (%) 97.2 97.4 96.9 97.4 98.2 97.4
95% CI for internal validity (%) 94.1e98.7 94.1e99.0 93.4e98.6 94.0e98.9 95.4e99.3 96.3e98.3
AAA
Patients reviewed 20 15 20 20 15 90
Variables total 260 195 260 260 195 1170
Data missing in Swedvasc 13a 7 0 21 21 62
Data not known in Swedvasc 0 0 3 0 0 3
Data not available from case records 0 0 3 2 0 5
Variables available for internal validation 273 188 254 239 174 1128
Data discrepancy between Swedvasc and case
records
15 13 7 3 5 43
Internal validity (%) 94.5 93.1 97.2 98.7 97.1 96.2
95% CI for internal validity (%) 91.1e96.7 88.5e95.9 94.4e98.7 96.4e99.6 93.5e98. 94.9e97.2
a All 13 variables were missing because the follow up visit was in another hospital.
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almost 30 years ago. The Swedvasc organisation performs
their own external validation annually by comparing the
number in the Swedvasc with the numbers in the admin-
istrative registry. In this external validation process the
external validity of Swedvasc for carotid endarterectomy
was 96% in 2012, which is comparable with the results here
when considering that all cases that did not match indi-
vidually were checked. This public external validation pro-
cess performed by Swedvasc is likely to drive the motivation
to register patients in Swedvasc.
The second question is: Are the recorded data accurate?
This is at least as important, if not more so than external
validation. It was found that data accuracy was good in
internal validation. The pre- and post-operative data were
correct in all hospitals, giving more that 95% internal data
validity in all ﬁve hospitals. In one of the validated hospitals
the pre-operative risk factors (diabetes and smoking) were
systematically missing. For the validator this information
was easily found from the case registries, so it seemed to be
a local cultural matter in registering the pre-operative risk
factors. The other variables in internal validation in this
particular hospital were correct.
The independence of the validators is a key issue in order
to achieve unbiased results in the validation process; hence,
validators from different countries were chosen to visit
Sweden. In the current project ﬁve of 20 hospitals that
perform vascular surgery in Sweden and participate in
Swedvasc were validated. The crucial question is how well
these ﬁve hospitals represent the whole of Swedvasc. The
validators were able to inﬂuence the centres selected
(Malmö, Stockholm), although two of them were selected
for geographical reasons, that is the hospitals were near theother hospitals that were chosen for validation (Vasterås
and Helsingborg). Only one centre was selected by the
representatives from Swedvasc (Uppsala). Owing to this
selection policy, the validators were conﬁdent that the se-
lection of the ﬁve hospitals was unbiased and would pro-
vide a representative view of vascular surgery in Sweden.
The hospitals did know before the visit that aortic and ca-
rotid surgery in 2012 would be validated. With the excep-
tion of Uppsala, which was the ﬁrst centre to be visited, the
time between informing the centres and the visit was less
than 4 weeks. There was therefore a theoretical possibility
of inﬂuencing the registry data before the visit although the
validators found no evidence that this had occurred.
Furthermore, it would have been an enormous workload to
check the data validity for internal validation as the cases
for validation were picked totally randomly. Furthermore,
the fact that all the studied pre-operative risk factors were
missing in one of the selected hospitals suggests that there
was no alteration of registry data prior to the visit. The
validators were given very detailed access to relevant data
in order to be able to perform the validation and found no
evidence of local centres failing to provide the required
information. This type of access is essential in order for the
validation process to be robust, and validation of other
countries in the future will need to include this require-
ment. The willingness of the Swedish vascular community to
allow external scrutiny of their data was considered by the
validators to be exceptional. One of the two validators had
language skills that allowed her to review the case histories
independently but the other needed a local person or
representative from Swedvasc to help with the patient re-
cords. This could be seen as another limitation of the
method (in addition to the fact that the hospitals were
Swedvasc Validation 807aware of the validation year), but is inevitable in interna-
tional validation. Many medical terms are common to both
languages, however, and both the validators felt that any
attempt to hide data would have been clear.
Almost all of the few differences between the case his-
tories and Swedvasc data were in the pre-operative data,
such as indication for the surgery, aneurysm diameter, de-
gree of carotid stenosis and risk factors (diabetes and
smoking). Post-operative complications were recorded
carefully and in all cases where discrepancy was found
between Swedvasc and case records, the deﬁnition of a
complication was not fulﬁlled (e.g. a few cases with signif-
icant creatinine elevation without dialysis were recorded as
renal complications although the deﬁnition of a renal
complication in Swedvasc is one that requires dialysis). This
indicates that post-operative complications were not
underestimated in the registry. The few cases that were
missing from Swedvasc were all emergency cases, and all of
these patients survived; therefore, the validation did not
demonstrate a failure to report cases with an adverse
outcome. Mortality data, both at 30 days and at 12 months
was correct in all the studied cases.
The most signiﬁcant problem in the current validation
process was obtaining the correct lists of hospital records
from ofﬁcial hospital records, and the structure of Swed-
vasc, which has several different modules. The vast ma-
jority of the cases that seemed to be missing from
Swedvasc were just recorded to a different module, and a
signiﬁcant number of module “mistakes” were found. This
of course does not affect the overall internal and external
validity but does have an inﬂuence on the reliability of the
reports extracted from Swedvasc. As a result, the numbers
of different type of operations based on modules in
Swedvasc could be seen as unreliable. There was a
learning curve to this both with regard to the validating
team and also the local team providing the data and the
validation process became more efﬁcient as the project
progressed.
The fact that most of the cases “missing” from the
Swedvasc registry were found in a different module in-
dicates that the registry may be too complex, and for this
reason reducing the number of modules within Swedvasc is
advisable. Although this issue could in theory have led to
cases being missed in the international comparisons that
have been performed by Vascunet, in practice the different
modules have been interrogated in order to identify all
relevant cases. In the future the increasing use of a variety
of endovascular techniques for infrarenal, juxtrenal, and
suprarenal aneurysms will make it even more difﬁcult to
deﬁne a true “infrarenal” group and therefore combining
these cases into one module seems sensible both within
Swedvasc and within other national systems.
This validation process has not examined the relevance or
subsequent use of the dataﬁelds that have been collected
within the Swedvasc database. The perceived impression is
that some of the dataﬁelds, in particular those that were
poorly completed, are of little relevance to the subsequent
evaluation of patient care. Further international work isrequired to deﬁne a robust dataset that excludes data ﬁelds
of little relevance.
SUMMARY AND RECOMMENDATIONS
The following recommendations for the Swedvasc registry
were made in the full report of the validation process
provided to the Swedish vascular teams.10
1. Procedure codes for identiﬁcation of procedures in local
hospital data and in Swedvasc should be identical.
2. Agreement should be reached (or followed more
accurately locally if agreement already exists) at a
national level regarding which procedures map to which
codes.
3. It should be clear in Swedvasc how to record procedures
done for different indications (e.g. an aortobifemoral
bypass graft for aneurysmal disease or occlusive
disease)
4. Consideration should be given to revising the different
modules within Swedvasc as there appears to be a
lack of consistency with regard to which cases are
entered into the different modules. Overall, reducing
the number of modules is recommended to avoid
confusion about which module to use for individual
cases.
5. A small number of data ﬁelds are responsible for the
majority of the variations found between Swedvasc
and local data. However, the validators were able to ﬁnd
this information from the case records. Consideration
should be given as to the beneﬁt of collecting the data
ﬁelds that are prone to missing data. If these are not
used for analysis they could be removed, if they are
used then centres should try and complete these ﬁelds.
The Vascunet team believe that this validation process
has demonstrated that international validation of registry
data is possible and this template could be used for other
similar validation exercises in the future. It is an important
step in improving registry data in order to allow meaningful
international comparison and thereby improve outcomes
from vascular intervention.
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